Medicinova (MNOV) Accounts Payables (2010 - 2026)
Medicinova (MNOV) posted quarterly Accounts Payables of $624995.0 for Q4 2025, down 43.31% year-over-year from $1.1 million in Q4 2024, and down 16.22% quarter-over-quarter from $745958.0 in Q3 2025.
Medicinova (MNOV) Accounts Payables (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Accounts Payables for 16 consecutive years, with $624995.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables fell 43.31% year-over-year to $624995.0; the TTM figure through Dec 2025 stood at $624995.0 (down 43.31% YoY), while the FY2025 annual figure was $624995.0, down 43.31% from the prior year.
- Accounts Payables slipped to $624995.0 in Q4 2025 per MNOV's latest filing, from $745958.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.1 million in Q4 2024 and bottomed at $402740.0 in Q4 2021.
- Historically, Accounts Payables has averaged $659113.9 across 5 years, with a median of $642526.0 in 2021.
- Annual changes were most pronounced in 2023 — Accounts Payables jumped 136.42% — and 2025, when it plunged 43.31%.
- Medicinova's Accounts Payables stood at $402740.0 in 2021, then climbed by 5.44% to $424646.0 in 2022, then surged by 136.42% to $1.0 million in 2023, then climbed by 9.82% to $1.1 million in 2024, then sank by 43.31% to $624995.0 in 2025.
- Business Quant data shows MNOV's Accounts Payables at $624995.0 in Q4 2025, $745958.0 in Q3 2025, and $569445.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | 950,503.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 950,503.00 |
| Dec 31, 2025 | 624,995.00 |
| Sep 30, 2025 | 745,958.00 |
| Jun 30, 2025 | 569,445.00 |
| Mar 31, 2025 | 718,891.00 |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 708,203.00 |
| Jun 30, 2024 | 667,695.00 |
| Mar 31, 2024 | 804,764.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 736,896.00 |
| Jun 30, 2023 | 548,221.00 |
| Mar 31, 2023 | 585,065.00 |
| Dec 31, 2022 | 424,646.00 |
| Sep 30, 2022 | 552,720.00 |
| Jun 30, 2022 | 642,634.00 |
| Mar 31, 2022 | 665,249.00 |
| Dec 31, 2021 | 402,740.00 |
| Sep 30, 2021 | 642,418.00 |
| Jun 30, 2021 | 607,155.00 |